Equities

Viemed Healthcare Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
VMD:NAQ

Viemed Healthcare Inc

Actions
Health CareHealth Care Providers
  • Price (USD)8.16
  • Today's Change-0.29 / -3.43%
  • Shares traded251.37k
  • 1 Year change+3.68%
  • Beta1.2504
Data delayed at least 15 minutes, as of Feb 12 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Viemed Healthcare, Inc. is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. The Company focuses on in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment solutions, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, oxygen concentrators, breast pumps for women, respiratory devices and other medical equipment. It offers in-home sleep apnea testing services. The Company also provides healthcare staffing and recruitment services.

  • Revenue in USD (TTM)254.79m
  • Net income in USD13.61m
  • Incorporated2016
  • Employees1.18k
  • Location
    Viemed Healthcare Inc625 E. KALISTE SALOOM RD.LAFAYETTE 70508United StatesUSA
  • Phone+1 (337) 504-3802
  • Fax+1 (337) 500-1972
  • Websitehttps://www.viemed.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
VMD:NAQ since
announced
Transaction
value
Lehan Drugs IncDeal completed06 May 202506 May 2025Deal completed11.32%28.20m
Data delayed at least 15 minutes, as of Feb 12 2026 21:00 GMT.

Institutional shareholders

39.59%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Sep 20252.96m7.78%
Forager Capital Management LLCas of 30 Sep 20252.74m7.20%
Thrivent Asset Management LLCas of 31 Mar 20252.71m7.12%
The Vanguard Group, Inc.as of 31 Dec 20251.59m4.17%
Nantahala Capital Management LLCas of 30 Sep 20241.14m2.99%
Goldman Sachs Asset Management LPas of 30 Sep 2025915.33k2.41%
BlackRock Advisors LLCas of 30 Sep 2025846.58k2.23%
Geode Capital Management LLCas of 31 Dec 2025797.65k2.10%
Kent Lake PR LLCas of 30 Sep 2025700.00k1.84%
Punch & Associates Investment Management, Inc.as of 30 Sep 2025671.36k1.77%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.